Lawyers Ponder Impact of COVID Cocktail Lawsuit

October 12, 2020

Cadwalader Intellectual Property Group Chair and Partner Dorothy Auth shares her insights on the timing of Allele Biotech’s patent infringement lawsuits against Pfizer and Regeneron in connection with their use of Allele’s patented molecules to develop COVID-19 treatments. Dorothy also comments on the case’s specific issue of how research tools are used in developing pharmaceutical products.

Read the article.

CadwaladerNews

CadwaladerSpotlight

Making a Mark on Our Communities: Pro Bono Report 2020

Cadwalader's research and intelligence platform provides analysis on changes in U.S. financial regulation. Subscribers receive a daily newsletter interpreting new laws, rules and enforcement actions that impact financial institutions.